Breaking
Friday, June 19, 2026

FDA News

🇺🇸 FDA Page 6

FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page

Track critical FDA approvals, regulatory updates, and policy shifts impacting drug development and market access in the US. Stay ahead of compliance.

Showing 61–72 of 391 articles

High impact NewsJun 5, 2026

Alabama Board of Medical Examiners Issues Warning on Non-FDA-Approved Peptides: What Pharma Teams Need to Know

FDA · 4 min

Dr. Sarah Mitchell
High impact NewsJun 5, 2026

Vertex Announces FDA Acceptance of Biologics License Application for Accelerated Approval of Povetacicept in IgA Nephropathy

FDA · IgA Nephropathy · 4 min

Dr. Sarah Mitchell
Critical impact NewsJun 5, 2026

Aurobindo Pharma OAI Classification: Implications for Drug Approvals

FDA · 5 min

Dr. Sarah Mitchell
High impact NewsJun 5, 2026

Lee, Tuberville Introduce Protections for Homeopathic Medicine with FDA Approval Framework

FDA · 4 min

Dr. Sarah Mitchell
Critical impact NewsJun 5, 2026

FDA Approves Ensitrelvir (XOCOVA) as First Oral Option for COVID-19 Post-Exposure Prophylaxis

FDA · COVID-19 · 5 min

Dr. Sarah Mitchell
High impact AnalysisJun 5, 2026

FDA Priority Review Voucher Program: Will Makary's Initiative Survive?

FDA · 7 min

Dr. Sarah Mitchell
High impact NewsJun 5, 2026

Texas AG Investigating Energy Drinks: What Pharma Teams Need to Know

FDA · 5 min

Dr. Sarah Mitchell
High impact AnalysisJun 5, 2026

FDA Voucher Program Under Fire: Pharma and Patient Groups Demand Pause

FDA · 5 min

Dr. Sarah Mitchell
High impact AnalysisJun 5, 2026

FDA Extends Comment Period for Real-Time Clinical Trials Pilot, AI Use in Studies

FDA · 6 min

Dr. Sarah Mitchell
High impact NewsJun 5, 2026

FDA Approves Companion Diagnostic for Inavolisib in HR+/HER2–, PIK3CA-Mutated Breast Cancer

FDA · oncology · 5 min

Dr. Sarah Mitchell
High impact NewsJun 5, 2026

The Peptide Reclassification Everyone's Talking About: A Pharmacist's Take on What RFK Jr's Announcement Actually Means — drug approvals

FDA · 5 min

Dr. Sarah Mitchell
High impact AnalysisJun 5, 2026

Pharma Pulse: 340B Uncertainty, Drug Shortages, and Wegovy's Global Debut

FDA · 8 min

Dr. Sarah Mitchell